API

A steroid is a type of organic compound that contains...

read more...

Pharma Intermediate

Pharmaceuticals refer to the drugs and medicines...

read more...

Speciality Chemicals

Specialty chemicals are those chemicals which is produced...

read more...

Products Under Devp.

New Products Under Development In response...

read more...

AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2009
(Rs. In Lacs)
PARTICULARS For the
Quarter Ended
For the
Quarter Ended
For the Year ended Ended
30th
June 2009
30th
June 2008
31st
Mar 2009
1. (a) (Net) Sales / Income from operations 11,490 10,171 37,650
(b) Other Operating Income - - -
2. Expenditure
(a). (Increase) / Decrease in stock in trade 218 161 695
(b). Consumption of raw materials. 5,824 5,962 21,077
(c). Purchase of Traded Goods 1,730 850 3,443
(d). Employees cost 321 256 1,114
(e). Depreciation 328 257 1,104
(f). Other expenditure 1,443 1,303 5,648
(g). Total Expenditure 9,864 8,790 33,081
3. Profit from Operating before Other Income 1,625 1,381 4,570
4. Other Income 2 4 17
5. Profit before Interest & Exceptional Items 1,627 1,385 4,587
6. Interest 416 560 2,272
7. Profit after Interest but before Exceptional Items 1,211 825 2,315
8. Exceptional Items - - -
9. Profit from Ordinary Activities before Tax 1,211 825 2,315
10. Tax Expenses (Includes) 481 173 810
Provision for Taxation 413 107 540
Provision for FBT - 3 15
Provision for Deffered Taxation 68 63 255
11. Net profit from ordinary Activities after Tax 731 652 1,505
12. Extraodinary Item (net of tax expenses )
13. Net Profit for the period 731 652 1,505
14. Paid-up Equity Share Capital of Rs.10/- each. 1,171 1,171 1,171
15. Reserves & Surplus (excluding revaluation reserves) - - 10,827
16. Basic E P S (in Rs.) 6.24 5.57 12.85
17. Public Shareholding
Number of Shares 5329891 5932388 5495949
Percentage of Total Shareholding 45.52 50.67 46.94
18. Promoters & Promoter Group Shareholding**
a) Pledged/Encumbered
- Number of Shares NIL N.A NIL
-Percentage of shares( as a percentage of the total shareholding of promoter and promoter group) NIL N.A NIL
-Percentage of shares( as a percentage of total sharecapital of the Company) NIL N.A NIL
b) Non-encumbered
- Number of Shares 6378659 N.A 6212601
-Percentage of shares( as a percentage of total shareholding of promoter and promoter group) 100 N.A 100
-Percentage of shares (as a percentage of total sharecapital of the Company) 54.48 N.A 53.06

Notes :

1. The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on 30th July, 2009.

2. Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted.

3. The figures of the previous periods have been regrouped and rearranged wherever necessary.

4. Number of Investors complaints (i) pending at the beginning of quarter 1 (ii) received during the quarter : 10 (Iii) redressed : 10 (iv) pending at the end of the quarter : 1.

For and on behalf of the Board

FOR AARTI DRUGS LIMITED

Sd/-

Place : Mumbai Harshit M Savla

Date : 30th Oct, 2009 (Jt. Managing Director)

 

Resource Download

Annual Report
Click here to download
annual report
Investor Presentation
Click here to download
Presentation

Copyright © 2010 Aarti Drugs Ltd. All Rights Reserved
Website Developed by : Sri Hema Infotech